Tightenining dose-volume constraints in oesophageal cancer to ensure best practice and further reduce toxicities. Geraint Lewis (Velindre Cancer Centre and @rttqa.bsky.social) presents modified #SCOPE2 trial constraints incorporated into the #PROTIEUS photon vs proton #clinicaltrial